SynOx Therapeutics raised $75m in Series B funding from Forbion, HealthCap and Bioqube Ventures.
10 April 2024
10 April 2024
Total investments received (USD): 135.96M
Round value (USD): 75M
Company: SynOx Therapeutics
Industry: BiotechHealth services
Related deals
NanoPhoria secured €83.5m in a series A w/ XGen Venture, Panakes Partner, Sofinnova Telethon, Sofinnova Partners, and Cdp Venture Capital.
Investments
01 October 2025
Trogenix raised €80m in Series A led by IQ Capital, joined by 4Bio, Cancer Research Horizons, Brain Tumour Fund, Eli Lilly, Meltwind, LongeVC and Calculus
Investments
01 October 2025
NRG Therapeutics closed a £50 million Series B funding round w/ British Business Bank, SV Health, M Ventures, Novartis, Criteria Bio Ventures, Omega Funds
Investments
01 September 2025
ProVerum raised $80m in a B round led by MVM Partners, joined by OrbiMed, Ireland Strategic Investment Fund, Gilde, Lightstone Ventures, Atlantic Bridge
Investments
10 August 2025
Charm Therapeutics raised $80M Series B round co-led by New Enterprise Associates and SR One, w/ OrbiMed, F-Prime Capital, Khosla Ventures, and NVIDIA
Investments
02 August 2025
Austria
Germany
Denmark
Estonia
Finland
Iceland
Lithuania
Norway
Portugal